(c) 2024 PillSync.com

lipitor atorvastatin calcium tablet film coated

1 INDICATIONS AND USAGE LIPITOR is indicated: • To reduce the risk of: o Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD o MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD o Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD • As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: o Adults with primary hyperlipidemia. o Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH). • As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia o Hypertriglyceridemia LIPITOR is an HMG-CoA reductase inhibitor (statin) indicated ( 1 ): • To reduce the risk of: o Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD. o MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD. o Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD. • As an adjunct to diet to reduce low-density lipoprotein (LDL-C) in: o Adults with primary hyperlipidemia. o Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to other LDL-C-lowering therapies to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia. • As an adjunct to diet for the treatment of adults with: o Primary dysbetaliproteinemia. o Hypertriglyceridemia.

parke-davis div of pfizer inc


5 years ago OVAL WHITE PD157 40 lipitor atorvastatin calcium tablet film coated

OVAL WHITE PD157 40

5 years ago OVAL WHITE PD157 40 lipitor atorvastatin calcium tablet film coated

PD157 40 OVAL WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING LIPITOR tablets are supplied as follows: Strength How Supplied NDC Tablet Description 10 mg of atorvastatin bottles of 90 0071-0155-23 white elliptical, film-coated tablets with “PD 155†on one side and “10†on the other 10 x 10 unit dose blisters 0071-0155-40 20 mg of atorvastatin bottles of 90 0071-0156-23 white elliptical, film-coated tablets with “PD 156†on one side and “20†on the other 10 x 10 unit dose blisters 0071-0156-40 40 mg of atorvastatin bottles of 90 0071-0157-23 white elliptical, film-coated tablets with “PD 157†on one side and “40†on the other 10 x 10 unit dose blisters 0071-0157-40 80 mg of atorvastatin bottles of 90 0071-0158-23 white elliptical, film-coated tablets with “PD 158†on one side and “80†on the other 8 x 8 unit dose blisters 0071-0158-92 Storage Store at controlled room temperature 20 - 25°C (68 - 77°F).


More pills like OVAL PD157 40

Related Pills

atorvastatin 10 MG Oral Tablet Lipitor

Parke-Davis Div of Pfizer Inc

atorvastatin 20 MG Oral Tablet Lipitor

Parke-Davis Div of Pfizer Inc












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site